US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

41.83

+0.23370.56%

Volume:208

Turnover:8.67K

Market Cap:31.37M

PE:- -

High:41.83

Open:41.59

Low:41.83

Close:41.59

52wk High:43.51

52wk Low:29.80

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.38

T/O Rate:0.03%

Dividend:0.14

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Natera, - Collaboration Includes Longitudinal Signatera Ctdna Testing for Agx101 Response Monitoring

THOMSON REUTERS

Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone

Ligand Targets $150-$250 Million in Annual Investments as Royalty Revenue Tops $225 Million in 2026 Guidance

Ligand Management Participates in Wells Fargo Healthcare Conference Fireside Chat

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?

Simply Wall St.

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live

Guardant Health to appeal federal district court judgment in TwinStrand case

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Sector Update: Healthcare

MT Newswires Live

GeneDx announces data published in Genetics in Medicine on genome sequencing

Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/HELX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":41.8273,"timestamp":1789502400000,"preClose":41.5936,"halted":0,"volume":208,"delay":0,"changeRate":0.005618652869672231,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Pre-Mkt","change":0.2337,"latestTime":"09-16 04:00:32 EDT","open":41.5936,"high":41.8273,"low":41.8273,"amount":8673.69984,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":41.8273,"sharesOutstanding":650000,"nav":41.622,"aum":31216701.03,"dividendRate":0.003381,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.5936,"preClose":41.8273,"latestTime":"19:30 EDT","volume":8,"amount":334.151,"timestamp":1789515006138,"change":-0.2337,"changeRate":-0.005587,"amplitude":0},"volumeRatio":0.38490008114174834,"impliedVol":0.0896,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.38490008114174834,"shares":750000,"dividePrice":0.1414,"high":41.8273,"amplitude":0,"preClose":41.5936,"low":41.8273,"week52Low":29.8,"pbRate":"--","week52High":43.5089,"institutionHeld":0,"latestPrice":41.8273,"eps":0,"divideRate":0.003381,"volume":208,"delay":0,"ttmEps":0,"open":41.5936,"prevYearClose":36.3062,"prevWeekClose":40.9874,"prevMonthClose":41.805,"prevQuarterClose":39.9651,"fiveDayClose":41.6426,"twentyDayClose":41.1366,"sixtyDayClose":35.8162},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662708603","title":"Natera, - Collaboration Includes Longitudinal Signatera Ctdna Testing for Agx101 Response Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708603?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:00","pubTimestamp":1787824827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0RC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","LU2264538146.SGD","BK4139","LU0012050646.USD","LU2065170008.USD","LU0963586101.USD","LU1064131342.USD","LU0345770993.USD","LU0345770308.USD","LU2065171311.SGD","LU0053671581.USD","LU2324357040.USD","LU0106261612.USD","GNOM","NTRA","LU2065171402.SGD","LU1988902786.USD","LU2065169927.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158123171","title":"Fujian Unveils Plans to Boost Cross-Strait Biotech and Medical Collaboration Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=1158123171","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158123171?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:00","pubTimestamp":1787814046,"startTime":"0","endTime":"0","summary":"On August 27, the \"15th Five-Year Plan for Health Development in Fujian Province\" was officially released, outlining key initiatives for the upcoming period.Among the highlighted measures, the plan...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","VHT","BK4581","BK4585","XBI","BK4588","159760","WDNA","HELX","BK4550","LABU","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662109537","title":"Ligand Targets $150-$250 Million in Annual Investments as Royalty Revenue Tops $225 Million in 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2662109537","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662109537?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:27","pubTimestamp":1787754449,"startTime":"0","endTime":"0","summary":"Ligand targets $150-$250 million in annual investments as royalty revenue tops $225 million in 2026 guidanceLigand guided to 2026 adjusted EPS of $9-$9.5 on total revenue of $270-$310 million.Royalty ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5nSN5c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LGND","BK4139","LU1559883803.SGD","LU0566484027.USD","IE0009354923.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662046718","title":"Ligand Management Participates in Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662046718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662046718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:02","pubTimestamp":1787742166,"startTime":"0","endTime":"0","summary":"Ligand management participates in Wells Fargo Healthcare Conference fireside chatLigand management will appear at three investor conferences in September 2026, including two fireside chats, one presen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7TCS5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","FTXO","IYF","LU0203347892.USD","IE00BQXX3F31.USD","LU2417539215.USD","LGND","TFNS","LU0170899867.USD","LU0128525689.USD","IE00BN0W2T93.GBP","LU1244550494.USD","LU0314104364.USD","LU2236285917.USD","LU0648001328.SGD","BK4566","LU2360032135.SGD","NDAQ","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","LU1791807156.HKD","LU0477156953.USD","LU1366192091.USD","LU2095319765.USD","BCDF","LU2210150020.SGD","LU1201861249.SGD","IE00B3QW5Z07.USD","IE0009354923.USD","LU0314106906.USD","LU0980610538.SGD","LU1244550577.SGD","IE00BSNM7G36.USD","SG9999014021.USD","IE00BKPKM429.USD","LU1144417596.USD","LU1559883803.SGD","LU0130517989.USD","LU0106831901.USD","LU0162691827.USD","LU1074936037.SGD","LU0130102774.USD","BK4559","LU0203345920.USD","BK4585","LU2456880835.USD","HELX","LU1267930227.SGD","IE00BN0W2V16.EUR","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180152997","title":"Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care","url":"https://stock-news.laohu8.com/highlight/detail?id=1180152997","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180152997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 11:36","pubTimestamp":1787715362,"startTime":"0","endTime":"0","summary":"On August 14, 2026, the National Healthcare Security Administration officially issued the coding standard for the Medical Insurance Pathology Cloud Index, marking another milestone in digital...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOMP","WDNA","HTEC","BMED","GDOC","GNOM","DTEC","HELX","IDNA","SYNB","XT","GNMX","TYNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662757992","title":"Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST","url":"https://stock-news.laohu8.com/highlight/detail?id=2662757992","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662757992?lang=en_us&edition=fundamental","pubTime":"2026-08-26 03:24","pubTimestamp":1787685840,"startTime":"0","endTime":"0","summary":"NeoGenomics, Inc. previously announced that Alicia Olivo, EVP, General Counsel & Business Development, would step down as General Counsel in September 2026 and remain with the company until early October 2026 to support the transition.\nThe company also secured a favorable North Carolina court ruling that invalidated key Natera patents, reducing legal friction around its RaDaR ST assay and altering the competitive landscape in molecular residual disease testing.\nWe’ll now examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/court-win-over-natera-patents-could-be-a-game-changer-for-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/court-win-over-natera-patents-could-be-a-game-changer-for-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LU0106261612.USD","LU2065169927.USD","FBT","LU0345770308.USD","LU1064131342.USD","LU2065170008.USD","LU2324357040.USD","LU0053671581.USD","LU0963586101.USD","NEO","LU1988902786.USD","LU2065171311.SGD","LU2065731478.USD","LU0345770993.USD","GNOM","BK4121","BK4196","LU2065171402.SGD","LU0012050646.USD","HELX","LU2264538146.SGD","NTRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020952","title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020952","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020952?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:22","pubTimestamp":1787606549,"startTime":"0","endTime":"0","summary":"Guardant Health Co-CEO AmirAli Talasaz disposes of USD 6.35 million in common sharesGuardant Health Co-CEO AmirAli Talasaz sold 37,500 common shares on Aug. 21, 2026 through the Talasaz Family Foundat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9NSL6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","EKG","BK4535","BK4551","PTH","BK4588","GDOC","GNOM","LFSC","LU0109394709.USD","BK4196","LU0320765992.SGD","GH","BK4585","LU0889565916.HKD","GNMX","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209693","title":"Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209693","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209693?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:23","pubTimestamp":1787603037,"startTime":"0","endTime":"0","summary":"Natera (NTRA) is back on investor radar after Stanley Druckenmiller's family office made the stock its largest holding. This coincides with strong revenue growth, higher test volumes, and improving free cash flow.\nSee our latest analysis for Natera.\nNatera’s recent news on clinical collaborations and higher test volumes sits alongside strong momentum in the stock. The 30 day share price return of 26.73% and 1 year total shareholder return of 104.36% point to building enthusiasm, while the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/natera-ntra-as-druckenmiller-backs-growth-story-is-the-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/natera-ntra-as-druckenmiller-backs-growth-story-is-the-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171311.SGD","HELX","LU2065169927.USD","LU0012050646.USD","GNOM","LU0053671581.USD","LU0963586101.USD","DCF","LU0106261612.USD","LU2065171402.SGD","LU2264538146.SGD","LU0345770993.USD","LU1988902786.USD","LU2065170008.USD","BK4139","LU2065731478.USD","NTRA","LU1064131342.USD","LU2324357040.USD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205974","title":"Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205974?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:41","pubTimestamp":1787600471,"startTime":"0","endTime":"0","summary":"Guardant Health  said Monday it will appeal the final judgment of a Delaware district court related to a patent infringement dispute with TwinStrand Biosciences and University of Washington.The company said execution of the court's final decision and collection of potential royalties are on hold, pending the appeal.The potential royalties do not apply to the company's current versions of Guardant Reveal and Shield, which feature updated technology. Additionally, the company has made design improvements to Guardant360 that would exclude the impact of potential ongoing royalties.The patents have also been preliminarily invalidated in separate challenges before the US Patent and Trademark Office, the company added.Shares fell around 3.5% in late afternoon trading.Price: 164.62, Change: -6.07, Percent Change: -3.56","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GH","EKG","GNOM","LU0109394709.USD","BK4535","LU0889565916.HKD","LU0320765992.SGD","BK4551","LFSC","BK4196","BK4585","GDOC","GNMX","BK4588","FFOX","PTH","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662030912","title":"Guardant Health to appeal federal district court judgment in TwinStrand case","url":"https://stock-news.laohu8.com/highlight/detail?id=2662030912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662030912?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:55","pubTimestamp":1787597714,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced it will appeal the final judgment from the U.S. District Court for the District of Delaware related to intellectual ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-to-appeal-federal-district-court-judgment-in-twinstrand-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","BK4585","BK4588","BK4535","BK4196","FFOX","GNOM","LU0109394709.USD","GNMX","GH","GDOC","LU0889565916.HKD","HELX","LU0320765992.SGD","LFSC","BK4551","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203463","title":"Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203463?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","GH","PTH","EKG","LFSC","HELX","GNMX","LU0109394709.USD","BK4585","BK4588","LU0889565916.HKD","GDOC","BK4535","BK4551","LU0320765992.SGD","BK4196","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203434","title":"Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203434","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","EKG","BK4585","BK4535","FFOX","BK4196","GNOM","HELX","LU0889565916.HKD","BK4551","BK4588","LU0320765992.SGD","PTH","LFSC","GNMX","LU0109394709.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034312","title":"Guardant Health to Appeal Federal District Court Judgment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034312?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:44","pubTimestamp":1787597047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","HELX","LFSC","BK4588","GDOC","LU0320765992.SGD","LU0109394709.USD","BK4196","EKG","BK4535","BK4551","FFOX","GNOM","LU0889565916.HKD","BK4585","GNMX","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662520885","title":"U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2662520885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662520885?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:55","pubTimestamp":1787590534,"startTime":"0","endTime":"0","summary":"UPDATE 2-U.S. court orders Guardant to pay $245 million in DNA sequencing patent disputeAug 24 (Reuters)-A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Bioscien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L18D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","SAIA","LU0889565916.HKD","EKG","BK4535","GNOM","LU0053671581.USD","HELX","BK4196","LU2065731478.USD","BK4588","FFOX","BK4551","GNMX","GDOC","BK4585","BK4232","PTH","LU0320765992.SGD","BK4022","GH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","HELX","IDNA","TMAT","BK4585","SYNB","JDOC","HTEC","PBE","GNOM","BMED","IBB","BK4588","FDIF","GDOC","MEDX","XT","LFSC","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279439","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279439","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279439?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:58","pubTimestamp":1787576324,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.2%,Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said. Guardant Health stock was down more than 1% premarket.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4135","LFSC","LU1883839398.USD","HELX","EKG","BK4137","PTH","STT","XBI","FFOX","BK4585","HCSG","BK4588","IBB","GNMX","LU0061475181.USD","BK4196","IE00B3QW5Z07.USD","GH","FDN","LU0029874061.USD","BK4581","LU1894683348.USD","LU0320765992.SGD","LU0109394709.USD","BK4535","IE0034235188.USD","LU0889565916.HKD","BK4550","IE00B64PRP62.GBP","LU0128526141.USD","LU1894683264.USD","XLV","GDOC","BK4551","GNOM","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279629","title":"GeneDx announces data published in Genetics in Medicine on genome sequencing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279629","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279629?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575230,"startTime":"0","endTime":"0","summary":"GeneDx (WGS) announced new data published in Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics, AC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-announces-data-published-in-genetics-in-medicine-on-genome-sequencing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-announces-data-published-in-genetics-in-medicine-on-genome-sequencing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","WGS","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661284276","title":"Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661284276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661284276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:20","pubTimestamp":1787574012,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-natera-ntra-healthequity-hqy-and-cspc-pharmaceutical-group-otherchjtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-natera-ntra-healthequity-hqy-and-cspc-pharmaceutical-group-otherchjtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169590202.USD","LU2210150020.SGD","HELX","BK4588","LU1064131342.USD","LU2264538146.SGD","LU2065171311.SGD","LU0053671581.USD","LU0128526141.USD","LU2065169927.USD","BK4581","NTRA","XBI","LU2210149790.SGD","BK4137","LU0963586101.USD","LU2065731478.USD","LU1169589451.USD","LU2324357040.USD","LU0106261612.USD","BK4139","HCSG","LU0345770308.USD","XLV","LU2095319765.USD","LU0029874061.USD","LU0012050646.USD","LABU","HQY","LU2065170008.USD","LU1988902786.USD","LU2065171402.SGD","LU0345770993.USD","BK4585","BK4154","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661752702","title":"Guardant Health Loses $245.2 Million Patent Infringement Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2661752702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661752702?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:51","pubTimestamp":1787572313,"startTime":"0","endTime":"0","summary":"Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said Monday.The final judgment, issued Friday, maintains a November 2023 jury verdict finding that Guardant Health willfully infringed two patents underlying TwinStrand's Duplex Sequencing technology in 11 royalty-bearing products and services, and awards TwinStrand and the University of Washington damages, accrued royalties and interest for infringement through May 31, 2026, the company said.The court ordered Guardant Health to pay a 6% royalty on sales of the covered products and services from June 1, 2026 until the expiration of the patents on March 15, 2033, the company said.Guardant is also required to provide quarterly accounting of US sales of the covered products and services, TwinStrand said.Guardant did not iimmediately reply to MT Newswires' request for comment.Shares of Guardant were down 1.6% in recent premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","HELX","BK4588","BK4535","GNOM","LFSC","LU0320765992.SGD","LU0889565916.HKD","PTH","EKG","GDOC","GNMX","GH","LU0109394709.USD","FFOX","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727387","title":"Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727387","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727387?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0889565916.HKD","BK4588","GNMX","LU0320765992.SGD","GNOM","PTH","GH","BK4196","HELX","LFSC","BK4551","FFOX","GDOC","EKG","BK4535","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}